WO2005095972A3 - Diagnostics and therapeutics for diseases associated with g protein-coupled receptor etb (etb) - Google Patents
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor etb (etb) Download PDFInfo
- Publication number
- WO2005095972A3 WO2005095972A3 PCT/EP2005/002336 EP2005002336W WO2005095972A3 WO 2005095972 A3 WO2005095972 A3 WO 2005095972A3 EP 2005002336 W EP2005002336 W EP 2005002336W WO 2005095972 A3 WO2005095972 A3 WO 2005095972A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- etb
- disorders
- therapeutics
- diagnostics
- protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04006665 | 2004-03-19 | ||
EP04006665.6 | 2004-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005095972A2 WO2005095972A2 (en) | 2005-10-13 |
WO2005095972A3 true WO2005095972A3 (en) | 2006-04-06 |
Family
ID=34961193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/002336 WO2005095972A2 (en) | 2004-03-19 | 2005-03-05 | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor etb (etb) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005095972A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2012009215A (en) * | 2010-02-23 | 2012-11-23 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor. |
FR2965810B1 (en) * | 2010-10-06 | 2012-12-28 | Commissariat Energie Atomique | ANTAGONIST ANTIBODY OF ENDOTHELIN RECEPTOR B-SUBTYPE B AND USES THEREOF |
WO2013152076A1 (en) * | 2012-04-04 | 2013-10-10 | The Brigham And Women's Hospital, Inc. | Compositions and methods for treating hypertension |
WO2014022679A2 (en) | 2012-08-02 | 2014-02-06 | Genentech, Inc. | Anti-etbr antibodies and immunoconjugates |
EP2879711A4 (en) | 2012-08-02 | 2016-03-16 | Genentech Inc | Anti-etbr antibodies and immunoconjugates |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002080960A2 (en) * | 2001-04-05 | 2002-10-17 | Medical Research Council | Treatment of neuropathologies associated with expression of tnf-alpha |
WO2003009805A2 (en) * | 2001-07-23 | 2003-02-06 | Brigham And Women's Hospital, Inc. | Analgesic methods using endothelin receptor ligands |
WO2003039539A2 (en) * | 2001-11-09 | 2003-05-15 | Merck Patent Gmbh | Use of endothelin receptor antagonists in the treatment of tumour diseases |
-
2005
- 2005-03-05 WO PCT/EP2005/002336 patent/WO2005095972A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002080960A2 (en) * | 2001-04-05 | 2002-10-17 | Medical Research Council | Treatment of neuropathologies associated with expression of tnf-alpha |
WO2003009805A2 (en) * | 2001-07-23 | 2003-02-06 | Brigham And Women's Hospital, Inc. | Analgesic methods using endothelin receptor ligands |
WO2003039539A2 (en) * | 2001-11-09 | 2003-05-15 | Merck Patent Gmbh | Use of endothelin receptor antagonists in the treatment of tumour diseases |
Non-Patent Citations (5)
Title |
---|
CARPENTER TODD ET AL: "Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression.", CIRCULATION RESEARCH, vol. 93, no. 5, 5 September 2003 (2003-09-05), pages 456 - 463, XP002339617, ISSN: 0009-7330 * |
KOHZUKI M ET AL: "ENDOTHELIN RECEPTORS IN ISCHEMIC RAT BRAIN AND ALZHEIMER BRAIN", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, NEW YORK, NY, US, vol. 26, no. SUPPL 3, 1995, pages S329 - S331, XP009023544, ISSN: 0160-2446 * |
LEHRKE INGO ET AL: "Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 12, no. 11, November 2001 (2001-11-01), pages 2321 - 2329, XP002339616, ISSN: 1046-6673 * |
OUE T ET AL: "Altered endothelin-3 and endothelin-B receptor mRNA expression in Hirschsprung's disease.", JOURNAL OF PEDIATRIC SURGERY. AUG 1999, vol. 34, no. 8, August 1999 (1999-08-01), pages 1257 - 1260, XP009052047, ISSN: 0022-3468 * |
YAGAMI T ET AL: "EFFCTS OF ENDOTHELIN B RECEPTOR AGONISTS ON AMYLOID BETA PROTEIN (25-35)-INDUCED NEURONAL CELL DEATH", BRAIN RESEARCH, AMSTERDAM, NL, vol. 948, no. 1/2, 6 September 2002 (2002-09-06), pages 72 - 81, XP001156395, ISSN: 0006-8993 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005095972A2 (en) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
WO2005095972A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor etb (etb) | |
WO2005095973A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54) | |
WO2005040828A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 49 (gpr49) | |
WO2004080373A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) | |
WO2005076007A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y12 (p2y12) | |
WO2005106489A3 (en) | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 5 (ccr5) | |
WO2005093091A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26) | |
WO2004082568A3 (en) | Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) | |
WO2005106488A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) | |
WO2005059546A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) | |
WO2005108998A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) | |
WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
WO2005040211A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) | |
WO2004104577A3 (en) | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 4 (5-ht4) | |
WO2004082572A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87) | |
WO2005040825A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20) | |
WO2005113788A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6) | |
WO2005073729A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y11 (p2y11) | |
WO2005003762A3 (en) | Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 2 (snsr2) | |
WO2005040824A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24) | |
WO2004082569A3 (en) | Diagnostics and therapeutics for diseases associated with dopamine receptor d3 (drd3) | |
WO2004097405A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor h7tba62 (h7tba62) | |
WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
WO2005040826A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 64 (gpr64) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |